• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability.

作者信息

Riordan J R, Ling V

出版信息

J Biol Chem. 1979 Dec 25;254(24):12701-5.

PMID:500733
Abstract
摘要

相似文献

1
Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability.从秋水仙碱通透性降低的中国仓鼠卵巢细胞突变体的质膜囊泡中纯化P-糖蛋白。
J Biol Chem. 1979 Dec 25;254(24):12701-5.
2
Modulation of drug permeability in Chinese hamster ovary cells. Possible role for phosphorylation of surface glycoproteins.
Biochim Biophys Acta. 1977 Jun 2;467(2):238-50. doi: 10.1016/0005-2736(77)90199-7.
3
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.一种调节中国仓鼠卵巢细胞突变体中药物通透性的表面糖蛋白。
Biochim Biophys Acta. 1976 Nov 11;455(1):152-62. doi: 10.1016/0005-2736(76)90160-7.
4
Altered drug permeability in mammalian cell mutants.
Adv Exp Med Biol. 1977;84:247-64. doi: 10.1007/978-1-4684-3279-4_12.
5
The purification and immunocytochemical localization of the major iodinatable cell surface glycoproteins of Chinese hamster ovary cells.
J Cell Sci. 1981 Dec;52:405-24. doi: 10.1242/jcs.52.1.405.
6
Multidrug-resistance phenotype in Chinese hamster ovary cells.中国仓鼠卵巢细胞中的多药耐药表型。
Cancer Treat Rep. 1983 Oct;67(10):869-74.
7
Isolation of a domain of the plasma membrane in Chinese hamster ovary cells which contains iodinatable, acidic glycoproteins of high molecular weight.在中国仓鼠卵巢细胞中分离出质膜的一个结构域，该结构域含有可碘化的高分子量酸性糖蛋白。
Biochim Biophys Acta. 1980 Jul 16;600(1):48-61. doi: 10.1016/0005-2736(80)90410-1.
8
Drug resistance and membrane alteration in mutants of mammalian cells.
Can J Genet Cytol. 1975 Dec;17(4):503-15. doi: 10.1139/g75-064.
9
Increased drug permeability in Chinese hamster ovary cells in the presence of cyanide.在氰化物存在的情况下，中国仓鼠卵巢细胞中的药物渗透性增加。
Biochim Biophys Acta. 1974 Dec 10;373(2):242-52. doi: 10.1016/0005-2736(74)90148-5.
10
Modulation of membrane drug permeability in Chinese hamster ovary cells.
Biochim Biophys Acta. 1976 Dec 14;455(3):900-12. doi: 10.1016/0005-2736(76)90059-6.

引用本文的文献

1
P-glycoprotein modulates the fluidity gradient of the plasma membrane of multidrug resistant CHO cells.P-糖蛋白调节多药耐药CHO细胞质膜的流动性梯度。
FEBS Lett. 2025 Aug;599(15):2167-2178. doi: 10.1002/1873-3468.70083. Epub 2025 May 31.
2
Understanding Cancer's Defense against Topoisomerase-Active Drugs: A Comprehensive Review.了解癌症对拓扑异构酶活性药物的防御机制：全面综述。
Cancers (Basel). 2024 Feb 6;16(4):680. doi: 10.3390/cancers16040680.
3
Emerging consensus on the mechanism of polyspecific substrate recognition by the multidrug transporter P-glycoprotein.
关于多药转运蛋白P-糖蛋白对多特异性底物识别机制的新共识。
Cancer Drug Resist. 2019 Sep 19;2(3):471-489. doi: 10.20517/cdr.2019.22. eCollection 2019.
4
The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors.人类ATP结合盒转运蛋白P-糖蛋白和ABCG2在癌症及内源性位点多药耐药中的作用：基于结构的抑制剂药物设计的未来机遇
Cancer Drug Resist. 2021;4(4):784-804. doi: 10.20517/cdr.2021.19. Epub 2021 Aug 4.
5
Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein.获得性耐药通过P-糖蛋白增强咪唑喹啉外排。
Pharmaceuticals (Basel). 2021 Dec 10;14(12):1292. doi: 10.3390/ph14121292.
6
Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.布列布鲁替尼（BMS-986195），一种布鲁顿酪氨酸激酶抑制剂，可使过表达P-糖蛋白的多药耐药癌细胞对化疗药物重新敏感。
Front Cell Dev Biol. 2021 Jul 19;9:699571. doi: 10.3389/fcell.2021.699571. eCollection 2021.
7
The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs.第三代 EGFR 抑制剂阿美替尼（HS-10296）使 ABCB1 过表达的多药耐药癌细胞对化疗药物重新敏感。
Biochem Pharmacol. 2021 Jun;188:114516. doi: 10.1016/j.bcp.2021.114516. Epub 2021 Mar 11.
8
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.骨肉瘤对传统治疗的耐药机制
Cancers (Basel). 2021 Feb 8;13(4):683. doi: 10.3390/cancers13040683.
9
Lysine 268 adjacent to transmembrane helix 5 of hamster P-glycoprotein is the major photobinding site of iodomycin in CHO B30 cells.仓鼠 P-糖蛋白跨膜螺旋 5 附近的赖氨酸 268 是碘霉素在 CHO B30 细胞中的主要光结合位点。
FEBS Open Bio. 2021 Apr;11(4):1084-1092. doi: 10.1002/2211-5463.13112. Epub 2021 Feb 28.
10
Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.厄达替尼使过表达ABCB1的多药耐药癌细胞对细胞毒性抗癌药物重新敏感。
Cancers (Basel). 2020 May 26;12(6):1366. doi: 10.3390/cancers12061366.